Search results for "GENE"
04:51

BeiGene: MCLA-129 is currently exploring indications in the field of lung cancer.

Jin10 Data August 19 - BeiGene announced on August 19 on the interactive platform that MCLA-129 is a bispecific antibody targeting EGFR and c-Met dual targets, currently exploring indications in the field of lung cancer. A recent Phase II study related to driver gene positivity and MET amplification has completed the enrollment of its first patient. If there are significant research developments, the company will disclose them in a timely manner.
More
MET-16.04%
  • 6
16:17

The deadlock over redistricting ends as Texas Democratic lawmakers return after "walking out."

Jin10 reported on August 18 that with the convening of the second special legislative session, Democratic lawmakers from Texas have returned to the state. Previously, they had left Texas for two weeks to block a vote on a new congressional district map supported by Trump, which could potentially give the Republican Party up to five additional seats in the U.S. House of Representatives. Democrats have stated that they have not given up this fight, and if the map is ultimately passed by the Republican-controlled state House and Senate and signed into law by the governor, they will resort to legal challenges. During the first special session, their departure had left the House without a quorum, leading to a standoff in legislative work. The Democratic leader of the state House, Gene Wu, stated: "Our return is to establish the necessary legal record to defeat this proposal."
More
TRUMP10.11%
20:02

Analyst: Trump's bill will support the stock market and is optimistic about cyclical industries.

On July 4, Jin10 reported that Gene Goldman, Chief Investment Officer of Cetera Investment Management, commented on the passage of the "Big and Beautiful" bill: the bill provides clear benefits for businesses and households, which often support corporate profits and stock prices. We will ignore the fact that the Congressional Budget Office estimates the bill will increase debt by about $3 to $3.4 trillion over the next decade. (The bill) may require a larger government debt issuance, which has already triggered caution in the bond market, evidenced by the rise in bond yields. Furthermore, these higher deficits may push up inflation expectations. From the perspective of the stock industry, cyclical sectors are expected to benefit, particularly energy companies (removal of green energy subsidies), industrial companies (increased infrastructure spending), the financial sector (reduced uncertainty, general deregulation, and a steepening yield curve), and the consumer goods sector (tax cuts).
More
TRUMP10.11%
  • 1
00:33

The Port of Los Angeles experienced a decline in throughput in May.

Jin10 data reported on June 16 that port officials revealed that the import volume at the busiest port in the U.S., the Port of Los Angeles, fell by 9% year-on-year in May. Due to the impact of the tariff policies during the Trump era, many companies chose to cancel or postpone shipments to cope with uncertainty, which could lead to continued poor performance at the Port of Los Angeles for the remainder of 2025. "May of this year was the lowest monthly throughput we have seen in over two years," said Gene Seroka, Executive Director of the Port of Los Angeles. "Many importers have already suspended related operations."
More
TRUMP10.11%
06:55

BIOProtocol teams up with CRISPRAI to accelerate scientific innovation in Decentralization, and the $COVID project will go live tomorrow.

CoinWorld News, January 8th, BIO Protocol announced a strategic partnership with CRISPR AI to jointly promote the future development of Decentralization Science (DeSci). This cooperation includes the strategic allocation of Nuclease DAO to BIO Treasury, injecting new momentum into the collaboration between the two parties in the field of gene editing and distributed scientific research. This initiative will accelerate innovation in the DeSci field. In addition, the heavyweight project Long COVID Labs ($COVID) on the BIO Protocol platform will be exclusively launched on BIO Launchpad on January 9, 2025. The project is led by current and former researchers at Stanford University, aiming to accelerate the research progress of over 100 million long COVID patients worldwide through Decentralization financing.
More
BIO1.02%
  • 3
  • 5
01:14

Jiuyuan Gene (02566.HK) starts its IPO today with an entrance fee of HKD 2537

Jinshi data news on November 20th, Jiuyuan Gene (02566.HK) will be listed from today to next Monday (25th), with a public offering price of HK$11.48-12.56 per share, offering 45.3988 million shares, 10% of which will be offered to the public in Hong Kong, and the rest will be internationally placed, raising up to HK$570 million. 200 shares per hand, the entry fee is HK$2537.33. The stock is expected to be listed next Thursday (28th).
03:58

Huada has released two nanopore sequencers with independent intellectual property rights, and the price for ordering is 400,000 yuan.

On September 9th, Jinshi Data News, Huawei Group has globally released the latest sequencing technology - CycloneSEQ sequencing technology. Two new types of gene sequencers with independent intellectual property rights, the Nanopore sequencer CycloneSEQ-WT02 (Chinese name "Wutong") and CycloneSEQ-WY01 (Chinese name "Wuyue"), are being introduced to the public for the first time. What's worth noting is that this signifies the arrival of the era of full-length reading at Huawei, making it the only institution in the world to possess gene sequencers with three different technical paths: excitation light, spontaneous light, and non-luminous.
19:49
Gene Goldman, Chief Investment Officer of Cetera Investment, said that the Fed's actions are like those of a CEO, who initially downplayed expectations of rate cuts to once or twice, but it is likely that they will reverse this later in the year with two or more rate cuts as inflation is rapidly receding.
  • 1
07:11
On June 4, Syngenta Group announced that it will provide authorization for high-quality gene editing and breeding technology for global academic research. Such licenses are available on the Group's innovation collaboration platform, ShootsbySyngenta. Gusui Wu, Global Head of Seed Research at Syngenta, said: "CRISPR technology has tremendous potential to advance crop innovation and create value for farmers. Scaling up CRISPR technology in agriculture can transform the way we breed crops, accelerate the discovery and application of innovations, and deliver higher-yielding, more resilient crops to growers. We invite universities and academic institutions from around the world to join us in driving innovation and promoting sustainable agriculture. ”
05:37
Novartis announced on its official WeChat account today that GLP-1 class drugs have become the focus of obesity drug development due to their excellent clinical data and efficacy. The activity detection of GLP-1RA drugs is a crucial step in the drug development process, and the current mainstream method is the luciferase reporter gene assay. Novartis can provide testing reagents and corresponding solutions to accelerate the development of GLP-1RA drugs. Currently, it has supplied multiple GLP-1RA drug development projects that have entered the clinical stage.
17:48
Golden Ten Data on May 2, asset management company Threadneedle analyst Gene Tannuzzo said that the US Intrerest Rate remains unchanged for a long time is not bad news for Treasury bonds, because the market expects to cut interest rates by only 25 basis points this year. "Investors now have an attractive entry point to lock in yields and improve total returns for longest years to come," he said. He also cited bonds as a way to protect portfolios from downside risks in equities, as stock indices are now approaching all-time highs. The Fed is widely expected to keep Intrerest Rate unchanged today and maintain a hawkish stance.
  • 1
10:04
The company announced in the evening that it has recently obtained the "Medical Device Registration Certificate (In Vitro Diagnostic Reagent)" for the soluble growth stimulating expression gene 2 protein detection kit (chemiluminescent immunoassay) issued by the Zhejiang Provincial Drug Administration.
09:30

The use of AI "cheating" by middle school students in the United States has become a trend, and Musk raised his hand in favor

Gene Munster, a well-known technology analyst, posted on the X platform that the use of generative AI tools by middle school students in the United States has become commonplace, and the situation has gotten out of control. This has reduced the amount of time they spend on homework by 50%. While school administrators think it's cheating, students don't think so. Munster wrote: "Initially, I was shocked when I heard about the widespread use of generative AI in schools. But on reflection, I think the students who used these tools were right. You must embrace these tools in order to gain a foothold in the job market of the future. Not only information workers, but skilled workforces undoubtedly need to leverage AI to maintain correlation. In response to Munster's point of view, Musk responded with a "100%" emoji, expressing his complete approval.
More
  • 1
  • 1
15:27
Since being acquired by Ripple for $250 million last year, most of Metaco's executives and marketing team members have left, and have now lost CTO Angel Nunez, sales executive Craig Perrin and product marketing director Mei Li Powell, as well as marketing officers Gene Peterson and Rahul Mudgal, according to people familiar with the matter. (CoinDesk)
XRP1.18%
  • 1
03:19
Odaily Planet Daily News Crypto KOL Tiffany Fong posted SBF's first photo during pretrial detention at the Brooklyn Metropolitan Detention Center (MDC) on the X platform. The photo was taken on December 17, 2023, and SBF (second from right) is thin and skewed, with unkempt beard and hair. In December 2023, it was reported that Tiffany Fong recently interviewed Gene Borrello, a former prisoner at the Metropolitan Detention Center (MDC) in Ruckering, who revealed that SBF was targeted for blackmail during the pretrial detention of the MDC because of his "timid personality" and "almost 80-year-old physique". Borrello said there have been inmates who have tried to scare SBF in order to extort protection money. Borrello remembers talking to SBF once, and SBF was acting very timid and nervous.
  • 1
04:45
According to a report by the Financial Associated Press on January 16, Hu Wenhui, deputy director of the State Intellectual Property Office, said that the legal protection of intellectual property rights will be comprehensively strengthened. We will further implement the newly revised Detailed Rules for the Implementation of the Patent Law, effectively implement the Measures for the Protection of Geographical Indication Products and the Provisions on the Registration and Administration of Collective Marks and Certification Marks, and accelerate the new round of revisions to the Trademark Law and its implementing regulations, the study of special legislation on geographical indications, and the revision and demonstration of the Regulations on the Protection of Layout Designs of Integrated Circuits. Deepen the establishment of rules for the protection of intellectual property rights in data. We will continue to improve the quality and efficiency of intellectual property examinations, improve the standards for patent examination in new fields and new forms of business such as big data, artificial intelligence, and gene technology, expand and accelerate the scale of examinations, and support the development of strategic emerging industries.
04:54
PANews reported on December 1 that according to Cointelegraph, FTX founder Sam Bankman-Fried (SBF) was worried about his own safety during his pretrial detention in Brooklyn Prison, and even considered paying other inmates for "protection". Former inmate Gene Borrello said in an interview that he had spent time with SBF and observed SBF looking out of place in prison and fearing for his safety. Borrello described other prisoners as cowardly and frail and thought he might have the funds to blackmail him by creating fear. However, since the SBF was housed in a separate area from regular prisoners, Borrello claimed that he advised the SBF not to pay protection money.
  • 1
  • 1
01:05
According to the "Kechuangban Daily" report, on September 19, local time, Google DeepMind announced that its research team created AlphaMissense based on the AlphaFold methodology - by using the protein sequence database and variant structure background, it can identify disease-causing missense mutations and The causative gene is unknown. AlphaMissense successfully predicted the pathogenicity of 216 million possible single amino acid changes in 19233 standard human proteins, resulting in predictions of 71 million missense mutations. Subsequently, AlphaMissense successfully predicted 89% of missense mutations, compared with only 0.1% of mutations that have been confirmed by human experts.
06:16
According to a report by China Business News on August 15, Huada Gene said in a recent survey that in terms of future technological change trends, the company will focus on the application of AI technology in the multi-learning big data and synthesis business, and continue to invest in the research and development of single-molecule sequencing technology. Clinical application of new technologies such as spatio-temporal omics technology.
  • 1
02:11
Gene Hoffman of Chia Network said in an interview that despite the decoupling between stocks and technology stocks this year, due to the continued mass adoption of Bitcoin and technology stocks, Bitcoin and technology stocks still have the potential to be correlated. Such tokens often tend to trade like tech stocks. Markets are expected to trade sideways in August due to the global holiday season, but all markets are expected to trade modestly higher in September due to employment support, the opening of the IPO market and the possibility of lower interest rates after an eventual U.S. rate hike.
20:52
Odaily Planet Daily News Chia Network announced the appointment of Effie Datson to its board of directors. "Effie's extensive experience and impressive record in financial services and passion for technology and innovation will provide valuable perspectives and insights to complement the expertise of our board," said Gene Hoffman, President and CEO of Chia Network. "We believe in Effie's ability to guide the company into its next phase of growth on the board, and we are delighted to welcome her to the Chia team." Datson was previously Global Head of the Barclays Family Office. A veteran of the financial services industry, she has also held leadership roles at Deutsche Bank, Goldman Sachs, Union Bank (UBP) and State Street, developing and marketing best-in-class investment opportunities for institutional and private wealth clients. In addition to his work in traditional finance, Datson served as a corporate director of a fintech startup that built a digital asset trading platform. (businesswire)
  • 1
04:30
According to Jinshi's news on July 21, MGI's Yang Meng team published a paper in Nature Machine Intelligence, a sub-journal of Nature, and released an algorithm model called "EvoPlay". It is reported that the algorithm draws on the way of the game of Go, and can train the agent to complete the protein evolution of specified function enhancement like an automatic driving. This breakthrough will provide new ideas in the field of protein design and be used to further optimize various tool enzymes used in gene sequencers.
07:05
Jinse Finance reported that according to U.S. Congressman Ritchie Torres on Thursday sent a letter to Deborah Jeffrey, Inspector General of the U.S. Securities and Exchange Commission, and a letter to Gene Dodaro, Comptroller of the Government Accountability Office, requesting two separate investigations of the U.S. Securities and Exchange Commission (SEC) because The SEC's approach to digital assets has been sloppy and rough. Rep. Torres has called for an investigation into the SEC's approach to cryptocurrencies.
  • 1
05:22
According to a report from IT House on July 13, researchers at the Massachusetts Institute of Technology have developed an AI tool called FrameDiff that uses generative artificial intelligence to design new protein structures with the aim of accelerating drug development and improving gene therapy. The design of novel protein structures remains a challenge in protein engineering across biomedical and chemical applications. FrameDiff can build proteins beyond natural variants, a method that can generate protein structures that differ from existing designs, and is expected to speed up the process of protein structure generation, thereby advancing progress in drug discovery, diagnostics, and industrial applications.
  • 1
03:21

U.S. bond bulls are optimistic about the decline in long-term yields, betting that the Fed will eventually defeat inflation

In the two years since U.S. inflation soared, the Federal Reserve has made limited progress in reining in rising prices. A group of investors in the bond market believe that not only will the Fed finally beat inflation, but long-term interest rates will also return to low levels as expected by the Fed. Gene Tannuzzo, global head of fixed income at Columbia Threadneedle Investments, thinks so. He said, "I think the Fed is slowly regaining its credibility on the issue of fighting inflation. As inflation moves closer to the target level, long-term interest rates will once again become a reliable anchor for yields." This view is not uncommon in the market.
More
  • 1
05:03
According to news from the Financial Associated Press on May 28, Zhou Lixin, deputy director of the Beijing Municipal Food and Drug Administration, said at the 6th China Medical and Health Industry Investment Forum of 50 People held by Changfa that he would invest in biopharmaceutical companies in Beijing, including Changping District. Provide a one-stop service system including customized consulting platform, resource sharing platform, personnel training platform, implementation of registration verification priority, production inspection priority, innovation achievement display base, etc.; will focus on supporting vaccines, gene drugs, cell drugs, traditional Chinese medicine, children Provide one-to-one pre-approval precise services for innovative drugs such as medication and clinically urgently needed drugs, as well as innovative medical devices such as artificial intelligence, import substitution, and clinically urgently needed drugs, and promote the connection between review and approval institutions and enterprises.
  • 2
Load More
Hot Tags

Hot Topics

More

Crypto Calendar

More
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)